GTX Inc (GTXI.OQ)

GTXI.OQ on NASDAQ Stock Exchange Global Market

0.89USD
19 Dec 2014
Price Change (% chg)

$-0.08 (-8.25%)
Prev Close
$0.97
Open
$0.97
Day's High
$0.97
Day's Low
$0.83
Volume
144,003
Avg. Vol
44,873
52-wk High
$2.34
52-wk Low
$0.41

GTXI.OQ

Chart for GTXI.OQ

About

GTx, Inc. is a biopharmaceutical company. The Company is developing selective androgen receptor modulators (SARMs) , a drugs with the potential to prevents and treat muscle wasting in patients with cancer and other musculoskeletal wasting or muscle loss conditions, including chronic sarcopenia (age related muscle loss). The... (more)

Overall

Beta: 1.20
Market Cap (Mil.): $141.05
Shares Outstanding (Mil.): 145.41
Dividend: --
Yield (%): --

Financials

  GTXI.OQ Industry Sector
P/E (TTM): -- 180.08 38.03
EPS (TTM): -0.48 -- --
ROI: -233.05 -0.62 18.26
ROE: -237.03 -1.77 19.16
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ Quantitative Report
$115.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks